Michelle J. Robertson has been serving as the Executive Vice President, Finance, Chief Financial Officer, and Treasurer at GERON CORP since September 25, 2023. With a robust background in finance and strategic leadership, Michelle brings a wealth of experience to her role at Geron. Prior to joining Geron, she held significant positions in the biotechnology and pharmaceutical industries, where she demonstrated her ability to drive financial performance and strategic growth. Her expertise in financial planning, capital markets, and corporate strategy has been instrumental in guiding companies through complex financial landscapes. Before her appointment at Geron, Michelle served as the CFO at a leading biotechnology firm, where she played a pivotal role in overseeing the company's financial operations and leading it through several successful funding rounds. Her strategic vision and financial acumen were key in navigating the company towards sustainable growth and profitability. Michelle's career also includes stints at major pharmaceutical companies, where she honed her skills in financial management and corporate governance. Her educational background includes a degree in Finance from a prestigious university, further solidifying her foundation in financial management. In her current role at GERON CORP, Michelle is responsible for overseeing the company's financial strategies, which include budgeting, forecasting, and investor relations. Her leadership is crucial as Geron continues to advance its mission in developing innovative therapies for cancer and other diseases. Michelle's strategic approach to finance and her ability to foster strong relationships with investors and stakeholders are expected to play a significant role in Geron's future success. Her appointment underscores Geron's commitment to strengthening its financial leadership as it moves forward with its clinical and commercial objectives.